• Ortho Kinematics

  Participated · Equity · Dec 2010

  Ortho Kinematics is a privately held diagnostic technology company focused on spine imaging informatics and committed to the idea that spine motion matters. Its flagship product is the VMA (Vertebral Motion Analysis) for the radiographic assessment of spinal instability and alignment; the company developed the VMA-Align module to assess sagittal alignment. The VMA technology had a commercial launch in 2015 and VMA-Align was developed in 2016. Ortho Kinematics recently closed an $18.6 million Series D equity financing to support continued commercialization and further development of the technology. The company is ramping a broader commercial launch and will expand sales, marketing, manufacturing, and R&D activities to meet demand. Leadership and industry commentators emphasized the need for improved functional spine diagnostics and suggested patients will benefit from wider commercialization. Ortho Kinematics is a privately held diagnostic technology company focused on spine imaging informatics and the biomechanical assessment of spinal motion. Its flagship product, the VMA (Vertebral Motion Analysis), provides radiographic assessment of spinal motion and instability. OKI has commercially tested the VMA on over 4,000 patients, demonstrating clinical traction. The company plans to expand U.S. and OUS commercialization of the VMA and to launch several new product features. To support commercialization and reimbursement efforts it appointed Margie Hans as Director of Reimbursement and Health Policy. Ortho Kinematics is located in Austin, Texas and is using new financing to strengthen its cash position. Ortho Kinematics develops the VMA (Vertebral Motion Analysis), a radiographic motion-analysis product for assessing spinal motion and instability. The company is a privately held diagnostic technology firm focused on spine imaging informatics and works with clinicians, researchers, and developers. OKI secured FDA clearance for the VMA and completed a limited-scale commercial launch. It is currently ramping up efforts for a full-scale commercial launch within the U.S. and Europe. The company plans to expand sales and marketing and continue limited research and development to support adoption. Ortho Kinematics is located in Austin, Texas. Ortho Kinematics is a privately held diagnostic technology company focused on spine imaging informatics based in Austin, Texas. Its core product is the VMA (Vertebral Motion Analysis) platform, a proprietary technology that pairs with standard fluoroscopes to capture video x-ray images while patients perform flexion, extension, and lateral bending movements. Proprietary image recognition software tracks motion at each vertebral level to produce biomechanical data; the VMA has patented intellectual property and received U.S. FDA clearance earlier this year. OKI is in a limited scale beta launch with strategic partners. The company plans to use new funding to commercialize VMA and to complete and expand its enterprise platform to assess the cervical spine in addition to current lumbar assessments. Leadership states the goal is to advance diagnostic standards for spine motion assessments. Ortho Kinematics develops the KineGraph VMA™, a vertebral motion analyzer that uses standard fluoroscopy and proprietary image-recognition software to track intervertebral movement. The device captures video images of the spine while patients are guided through flexion, extension, and side‑bending to produce movement information at each vertebral level. The KineGraph VMA™ is an investigational device currently in clinical studies at seven sites across the United States and United Kingdom. The company plans to use the new funds to expand its ongoing clinical study, pursue regulatory clearance, and hire key sales personnel. Ortho Kinematics is led by founder and CEO Adam Deitz and is based in Austin, Texas. It closed $2M of new funding in the announced round.

No current team members are available.